IQV
NYSE
$203.95
IQVIA Holdings Inc (IQV)
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $232 (+13.75%)
Market Cap
$35B
EPS 5Y CAGR
+30.82%
Forward P/E
16.13
P/E Ratio
25.28
Price Chart
Valuation
Market Cap$35B
P/E25.28
Forward P/E16.13
PEG2.67
P/S2.10
P/B5.58
Profitability
Total Revenue (TTM)$17B
Gross Profit (TTM)$5.49B
EBITDA$3.37B
Profit Margin6.6%
Operating Margin12.4%
EPS$8.18
Financial Health
Debt-to-Equity254.5%
Free Cash Flow Yield7.83%
Growth & Risk
EPS 5Y CAGR+30.82%
Revenue 5Y CAGR+6.72%
FCF 5Y CAGR+0.31%
Beta (5Y)1.02
Sharpe Ratio0.64